Semaglutide Semaglutide is a long-acting GLP-1 RA approved both globally to treat type 2 diabetes and long-term weight management in obese or overweight patients aged 12 years and older - consistent with liraglutide
Only 2 days have passed, so you inject Saturday afternoon
Choose Injections If: You want a proven, fully licensed UK weight loss option, prefer only thinking about your medication once a week, and are comfortable using a tiny needle
Retatrutide is emerging as a multi-pathway, short-protein therapeutic with potential benefits that reach into metabolic health, visceral fat reduction, and possibly even longevity
Wondering what these medications doand why theyre receiving so much attention
It is not a GLP-1 agonist drug, nor is it intended to replace GLP-1 agonist drugs